Clinical Trial Update: Sorafenib in Newly Diagnosed High Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating sorafenib in newly diagnosed high-grade glioma, including glioblastoma, gliosarcoma, and various anaplastic gliomas. The study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: COMPLETED